Abstract
BackgroundBispecific antibodies (BsAb) that target dual tumor-associated antigens can invoke synergistic effects between two signaling pathways, increase target tissue specificity, and reduce systemic toxicity. Combining antibody-mediated specific targeting with potent...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have